Interaction between the pRb2/p130 C-terminal domain and the N-terminal portion of cyclin D3

Journal of Cellular Biochemistry

Volumn 75, Issue 4, 1999, Pages 698-709

  Bonetto, Francesco ^a   Fanciulli, Maurizio ^a   Battista, Tullio ^a   De Luca, Antonio ^a,b   Russo, Patrizia ^a   Bruno, Tiziana ^a   De Angelis, Roberta ^a   Di Padova, Monica ^a   Giordano, Antonio ^b   Felsani, Armando ^c   Paggi, Marco C ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c CNR   (Italy)

Author keywords

Cell cycle; Cyclin D3; Differentiation; Phosphorylation; Protein protein interaction; Rb2 p130

Indexed keywords

CYCLIN D3; CYCLIN DEPENDENT KINASE; GENE PRODUCT;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 0033573310     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19991215)75:4<698::AID-JCB15>3.0.CO;2-7     Document Type: Article

References (75)

1. Adams PD, Li XT, Sellers WR, Baker KB, Leng XH, Harper JW, Taya Y, Kaelin WG Jr. 1999. Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes. Mol Cell Biol 19:1068-1080.
2. Baldi A, De Luca A, Claudio PP, Baldi F, Giordano GG, Tommasino M, Paggi MG, Giordano A. 1995. The Rb2/ p130 gene product is a nuclear protein whose phosphorylation is cell cycle regulated. J Cell Biochem 59:402-408.
3. Baldi A, Esposito V, De Luca A, Howard CM, Mazzarella G, Baldi F, Caputi M, Giordano A. 1996. Differential expression of the retinoblastoma gene family members pRb/ p105, p107, and pRb2/p130 in lung cancer. Clin Cancer Res 2:1239-1245.
4. Barbeau D, Marcellus RC, Bacchetti S, Bayley ST, Branton PE. 1992. Quantitative analysis of regions of adenovirus E1A products involved in interactions with cellular proteins. Biochem Cell Biol 70:1123-1134.
5. Bartkova J, Lukas J, Strauss M, Bartek J. 1998. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17:1027-1037.
6. 1 cyclin complexes. Genes Dev 9:1340-1353.
7. Bernards R, Schackleford GM, Gerber MR, Horowitz JM, Friend SH, Schartl M, Bogenmann E, Rapaport JM, McGee T, Dryja TP. 1989. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc Natl Acad Sci USA 86:6474-6478.
8. Bookstein R, Shew JY, Chen PL, Scully P, Lee WH. 1990. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247:712-715.
9. Buchkovich K, Duffy LA, Harlow E. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
10. Castaño E, Kleyner Y, Dynlacht BD. 1998. Dual cyclin-binding domains are required for p107 to function as a kinase inhibitor. Mol Cell Biol 18:5380-5391.
11. Chen PL, Scully P, Shew JY, Wang JY, Lee WH. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198.
12. Chien CT, Bartel PL, Sternglanz R, Fields S. 1991. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 88:9578-9582.
13. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B, Giordano A. 1994. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54:5556-5560.
14. Claudio PP, De Luca A, Howard CM, Baldi A, Firpo EJ, Koff A, Paggi MG, Giordano A. 1996. Functional analysis of pRb2/p130 interaction with cyclins. Cancer Res 56:2003-2008.
15. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, Harlow E, Beach D, Weinberg RA, Jacks T. 1996. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644.
16. Connell-Crowley L, Harper JW, Goodrich DW. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 8:287-301.
17. De Luca A, MacLachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K, Giordano A. 1997. A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity. J Biol Chem 272:20971-20974.
18. Dong F, Cress WDJ, Agrawal D, Pledger WJ. 1998. The role of cyclin D3-dependent kinase in the phosphorylation of p130 in mouse BALB/c 3T3 flbroblasts. J Biol Chem 273:6190-6195.
19. Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511.
20. Ewen ME. 1994. The cell cycle and the retinoblastoma protein family. [Review.] Cancer Metastas Rev 13:45-66.
21. Ewen ME, Xing YG, Lawrence JB, Livingston DM. 1991. Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164.
22. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
23. Feilotter HE, Hannon GJ, Ruddell CJ, Beach D. 1994. Construction of an improved host strain for two hybrid screening. Nucleic Acids Res 22:1502-1503.
24. Gietz D, St Jean A, Woods RA, Schiestl RH. 1992. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res 20:1425.
25. Giordano A, Lee JH, Scheppler JA, Herrmann C, Harlow E, Deuschle U, Beach D, Franza BR Jr. 1991. Cell cycle regulation of histone H1 kinase activity associated with the adenoviral protein E1A. Science 253:1271-1275.
26. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302.
27. Hannon GJ, Demetrick D, Beach D. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev 7:2378-2391.
28. Helin K, Holm K, Niebuhr A, Eiberg H, Tommerup N, Hougaard S, Poulsen HS, Spang-Thomsen M, Norgaard P. 1997. Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. Proc Natl Acad Sci USA 94:6933-6938.
29. Helin K, Lees JA, Vidal M, Dyson N, Harlow E, Fattaey A. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
30. Hiebert SW. 1993. Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 13:3384-3391.
31. Horton LE, Qian Y, Templeton DJ. 1995. G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms. Cell Growth Diff 6:395-407.
32. Huang HJ, Yee JK, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EY, Lee WH. 1988. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563-1566.
33. Hurford RK Jr, Cobrinik D, Lee MH, Dyson N. 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 11:1447-1463.
34. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. 1992. Effects of an Rb mutation in the mouse. Nature 359:295-300.
35. Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA. 1997. The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14:1789-1797.
36. Johnson DG. 1995. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. Oncogene 11:1685-1692.
37. Kiess M, Gill RM, Hamel PA. 1995. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Diff 6:1287-1298.
38. Kim KK, Soonpaa MH, Wang H, Field LJ. 1995. Developmental expression of p107 mRNA and evidence for alternative splicing of the p107 (RBL1) gene product. Genomics 28:520-529.
39. Klein G. 1987. The approaching era of the tumor suppressor genes. Science 238:1539-1545.
40. Knudsen ES, Wang JYJ. 1996. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem 271:8313-8320.
41. Lacy S, Whyte P. 1997. Identification of a p130 domain mediating interactions with cyclin A cdk2 and cyclin E cdk2 complexes. Oncogene 14:2395-2406.
42. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis [see comments]. Nature 359:288-294.
43. Li Y, Graham C, Lacy S, Duncan AM, Whyte P. 1993. The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev 7:2366-2377.
44. Lin BT, Gruenwald S, Morla AO, Lee WH, Wang JY. 1991. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J 10:857-864.
45. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. 1995. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503-506.
46. Lundberg AS, Weinberg RA. 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol 18:753-761.
47. Mayol X, Graña X, Baldi A, Sang N, Hu Q, Giordano A. 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:2561-2566.
48. Olopade OI, Jenkins RB, Ransom DT, Malik K, Pomykala H, Nobori T, Cowan JM, Rowley JD, Diaz MO. 1992. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 52:2523-2529.
49. Paggi MG, Martelli F, Fanciulli M, Felsani A, Sciacchitano S, Varmi M, Bruno T, Carapella CM, Floridi A. 1994. Defective human retinoblastoma protein identified by lack of interaction with the E1A oncoprotein. Cancer Res 54:1098-1104.
50. Paggi MG, Baldi A, Bonetto F, Giordano A. 1996. Retinoblastoma protein family in cell cycle and cancer: a review. J Cell Biochem 62:418-430.
51. Paramio JM, Laín S, Segrelles C, Lane EB, Jorcano JL. 1998. Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation. Oncogene 17:949-957.
52. Peeper DS, Parker LL, Ewen ME, Toebes M, Hall FL, Xu M, Zantema A, van der Eb AJ, Piwnica Worms H. 1993. A-and B-type cyclins differentially modulate substrate specificity of cyclin-cdk complexes. EMBO J 12:1947-1954.
53. Pertile P, Baldi A, De Luca A, Bagella L, Virgilio L, Pisano MM, Giordano A. 1995. Molecular cloning, expression, and developmental characterization of the murine retinoblastoma-related gene Rb2/p130. Cell Growth Diff 6:1659-1664.
54. Qin XQ, Chittenden T, Livingston DM, Kaelin WG Jr. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev 6:953-964.
55. Raschellà G, Negroni A, Skorski T, Pucci S, Nieborowska-Skorska M, Romeo A, Calabretta B. 1992. Inhibition of proliferation by c-myb antisense RNA and oligodeoxynucleotides in transformed neuroectodermal cell lines. Cancer Res 52:4221-4226.
56. Raschellà G, Negroni A, Sala A, Pucci S, Romeo A, Calabretta B. 1995. Requirement of B-myb function for survival and differentiative potential of human neuroblastoma cells. J Biol Chem 270:8540-8545.
57. Raschella G, Tanno B, Bonetto F, Amendola R, Battista T, De Luca A, Giordano A, Paggi MG. 1997. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation. J Cell Biochem 67:297-303.
58. Raschellà G, Tanno B, Bonetto F, Negroni A, Claudio PP, Baldi A, Amendola R, Calabretta B, Giordano A, Paggi MG. 1998. The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation. Cell Death Diff 5:401-407.
59. Richon VM, Lyle RE, McGehee RE Jr. 1997. Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation. J Biol Chem 272:10117-10124.
60. Riley DJ, Lee EYHP, Lee W-H. 1994. The retinoblastoma protein: more than a tumor suppressor. Annu Rev Cell Biol 10:1-29.
61. Seeger RC, Danon YL, Rayner S, Hoover F. 1982. Definition of a Thy-1 determinant on human neuroblastoma, glioma, sarcoma and teratoma cells with a monoclonal antibody. J Immunol 128:983-989.
62. Sidle A, Palaty C, Dirks P, Wiggan O, Kiess M, Gill RM, Wong AK, Hamel PA. 1996. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit Rev Biochem Mol Biol 31:237-271.
63. Stiegler P, De Luca A, Bagella L, Giordano A. 1998. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Cancer Res 58:5049-5052.
64. Susini T, Baldi F, Howard CM, Baldi A, Taddei G, Massi D, Rapi S, Savino L, Massi G, Giordano A. 1998. Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial. J Clin Oncol 16: 1085-1093.
65. Szekely L, Jiang WQ, Bulic Jakus F, Rosen A, Ringertz N, Klein G, Wiman KG. 1992. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Diff 3:149-156.
66. Takahashi R, Hashimoto T, Xu HJ, Hu SX, Matsui T, Miki T, Bigo Marshall H, Aaronson SA, Benedict WF. 1991. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci USA 88:5257-5261.
67. Weinberg RA. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
68. Welch PJ, Wang JYJ. 1993. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779-790.
69. Welch PJ, Wang JYJ. 1995. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment. Genes Dev 9:31-46.
70. Whitaker LL, Su HY, Baskaran R, Knudsen ES, Wang JYJ. 1998. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): contribution from the RB C pocket. Mol Cell Biol 18:4032-4042.
71. Woo MSA, Sánchez I, Dynlacht BD. 1997. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol Cell Biol 17:3566-3579.
72. Xiao Z-X, Chen J, Levine AJ, Modjtahedi N, Xing J Sellers WR, Livingston DM. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375:694-698.
73. 1 cyclin-associated kinases. Proc Natl Acad Sci USA 93:4633-4637.
74. 1/S cyclin-dependent kinases. J Biol Chem 272:12738-12746.
75. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen ME, Livingston DM, Dyson N, Harlow E. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7:1111-1125.